mitomycin has been researched along with olaparib in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auerbach, AD; Kim, Y; Lach, FP; Smogorzewska, A; Spitz, GS; Veturi, U | 1 |
Benes, CH; Birkelbach, M; Dahm-Daphi, J; Daly, B; Ebright, MI; Ferraiolo, N; Gheorghiu, L; Kachnic, LA; O'Hara, C; Pfäffle, HN; Sequist, LV; Spencer, C; Whetstine, JR; Willers, H; Zou, L | 1 |
Azad, NS; De Jesus-Acosta, A; Donehower, RC; Fine, RL; Goggins, M; Jaffee, EM; Johnson, BA; Laheru, DA; Le, DT; Myzak, MC; Oberstein, PE; Yarchoan, M; Zheng, L | 1 |
Gu, S; Jin, L; Ma, J; Ni, X; Pan, Q; Wang, J; Xu, M; Zhen, N; Zhu, J | 1 |
4 other study(ies) available for mitomycin and olaparib
Article | Year |
---|---|
Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4.
Topics: Camptothecin; Cell Line; Cross-Linking Reagents; DNA; DNA Mutational Analysis; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Endodeoxyribonucleases; Endonucleases; Fanconi Anemia; Humans; Mitomycin; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Interaction Mapping; Protein Structure, Tertiary; Recombinant Fusion Proteins; Recombinases; Topoisomerase I Inhibitors | 2013 |
Detection of impaired homologous recombination repair in NSCLC cells and tissues.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA Damage; Fanconi Anemia Complementation Group D2 Protein; Humans; Immunoenzyme Techniques; Lung Neoplasms; Microscopy, Fluorescence; Mitomycin; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Rad51 Recombinase; Recombination, Genetic; Recombinational DNA Repair; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2013 |
Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cisplatin; Female; Humans; Irinotecan; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pancreatic Neoplasms; Phthalazines; Piperazines; Retreatment; Treatment Outcome | 2017 |
Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carrier Proteins; Cell Growth Processes; Cell Line, Tumor; DNA Damage; Drug Synergism; Endodeoxyribonucleases; Ginsenosides; Hep G2 Cells; Hepatoblastoma; Humans; Hydroxyurea; Liver Neoplasms; Male; Mice; Mice, Nude; Mitomycin; Nuclear Proteins; Phthalazines; Piperazines; Random Allocation; Recombinational DNA Repair; Xenograft Model Antitumor Assays | 2018 |